KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Other Non-Current Assets (2016 - 2025)

Bausch Health Companies' Other Non-Current Assets history spans 17 years, with the latest figure at $378.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 4.13% year-over-year to $378.0 million; the TTM value through Dec 2025 reached $378.0 million, up 4.13%, while the annual FY2025 figure was $378.0 million, 4.13% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $378.0 million at Bausch Health Companies, down from $382.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $617.0 million in Q1 2021 and bottomed at $307.0 million in Q4 2023.
  • The 5-year median for Other Non-Current Assets is $340.5 million (2021), against an average of $371.7 million.
  • The largest YoY upside for Other Non-Current Assets was 62.4% in 2021 against a maximum downside of 48.8% in 2021.
  • A 5-year view of Other Non-Current Assets shows it stood at $340.0 million in 2021, then dropped by 4.12% to $326.0 million in 2022, then dropped by 5.83% to $307.0 million in 2023, then grew by 18.24% to $363.0 million in 2024, then increased by 4.13% to $378.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Other Non-Current Assets are $378.0 million (Q4 2025), $382.0 million (Q3 2025), and $388.0 million (Q2 2025).